UCB Beats Apotex's IP Suit Over Drugmaking Process

Law360, Los Angeles (September 9, 2013, 4:34 PM EDT) -- A Florida federal judge ruled Friday in favor of drugmaker UCB Inc. and against Canadian company Apotex Inc., which had accused UCB of copying a patented manufacturing process for a blood pressure medication, finding that the patent should never have been issued.

The decision comes after U.S. District Judge Donald M. Middlebrooks refused to dismiss the complaint in January, saying a lack of details about UCB’s process prevented him from determining no violation occurred. Apotex sued UCB, Pfizer Inc. and other rival generic-drug makers in separate...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.